Partners of Choice: What Biotech Wants, According to BCG's Latest Sell-Side Survey
Executive Summary
Roche and Merck led a group of companies rated as top partners in a survey published in December 2010 by the Boston Consulting Group (BCG). The goal of the BCG survey, is to determine the key characteristics companies are looking for in a partner, and which buy-siders are best fulfilling those wishes. The survey was sent to about 500 head of business development and chief executives during the summer of 2010, and the results are based on approximately 100 responses.
You may also be interested in...
Investors Go Beserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.